| 0.0033 Data as of 9:38am ET |  0.00 / 0.00%Today’s Change | 0.00 Today|||52-Week Range 0.00 | +120.00% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $122.5K |
Company Description
Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA.
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Jo-Ann B. Maltais, PhD | Vice President-Scientific Affairs |
| Dale L. Richardson, MBA | Vice President-Business Development |
| W. Michael Kelley | Director-Investor Relations |
.
